Xconomy’s Digital Events →
December 3, 2020 · New York
Bio, Tech, & Beyond founders Joseph Jackson (left) and Kevin Lustig
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
From Our Editors · Special Report
The AI, Big Data, and R&D Boom
Sponsored · Whitepaper
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.